Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Inv. presentation
|
|
Sorrento Therapeutics, Inc. (SRNE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
SC 13G/A
| Sorrento Therapeutics, Inc. reports a 2.6% stake in CELULARITY INC. |
| 03/10/2023 |
SC 13G/A
| STATE STREET CORP reports a 0% stake in EXIT FILING SORRENTO THERAPEUTICS INC |
| 03/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 0% stake in SORRENTO THERAPEUTICS INC |
| 02/09/2023 |
SC 13G/A
| STATE STREET CORP reports a 10.7% stake in AMEMDED FILING SORRENTO THERAPEUTICS INC |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.3% stake in Sorrento Therapeutics Inc. |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Ally Bridge Group Capital Partners II, L.P. reports a 2.9% stake in TO AMEND THE SCHEDULE 13D FILED BY ABG II-SO LIMITED AND RELATED PARTIES ON JULY 10, 2017 SORRENTO THERAPEUTICS, INC. |
| 02/10/2020 |
SC 13G/A
| Asia Pacific MedTech Ltd reports a 9.1% stake in SORRENTO THERAPEUTICS, INC. |
| 02/10/2020 |
SC 13G/A
| Famous Sino Ltd reports a 6.2% stake in SORRENTO THERAPEUTICS, INC. |
| 02/10/2020 |
SC 13G/A
| China In Shine Investment Ltd reports a 7% stake in SORRENTO THERAPEUTICS, INC. |
| 02/06/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.1% stake in SORRENTO THERAPEUTICS INC |
| 12/13/2018 |
SC 13G/A
| Asia Pacific MedTech Ltd reports a 9.1% stake in SORRENTO THERAPEUTICS , INC. |
| 12/13/2018 |
SC 13G/A
| China In Shine Investment Ltd reports a 6.9% stake in SORRENTO THERAPEUTICS , INC. |
| 12/13/2018 |
SC 13G/A
| Famous Sino Ltd reports a 6.6% stake in SORRENTO THERAPEUTICS, INC. |
| 06/27/2018 |
SC 13G/A
| Famous Sino Ltd reports a 6.4% stake in SORRENTO THERAPEUTICS, INC. |
| 06/22/2018 |
SC 13G/A
| Asia Pacific MedTech Ltd reports a 8.8% stake in SORRENTO THERAPEUTICS, INC. |
| 06/22/2018 |
SC 13G/A
| China In Shine Investment Ltd reports a 6.7% stake in SORRENTO THERAPEUTICS, INC. |
| 05/22/2018 |
SC 13G/A
| Xianjian Advanced Technology Ltd reports a 8.4% stake in SORRENTO THERAPEUTICS, INC. |
| 02/12/2018 |
SC 13G/A
| Wildcat Capital Management, LLC reports a 2.2% stake in Sorrento Therapeutics, Inc. |
| 05/15/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 3.3% stake in Sorrento Therapeutics, Inc. |
| 02/10/2017 |
SC 13G/A
| NantKwest, Inc. reports a 0% stake in NANTKWEST, INC. |
| 02/05/2016 |
SC 13G/A
| AISLING CAPITAL III LP reports a |
| 01/25/2012 |
SC 13G/A
| Sorrento Therapeutics, Inc. reports a 14.8% stake in SORRENTO THERAPEUTICS, INC. |
|
|